Chenghao Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Chenghao Li has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Jinmao Zhu
Department of Neurology, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, Institute of Neuroscience, The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, China
2 shared publications - Juehua Zhu
Department of Neurology, The First Affiliated Hospital of Soochow University, Suzhou, China
2 shared publications - Li Wu
Department of Neurology, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, Institute of Neuroscience, The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, China
2 shared publications - Yongjun Jiang
Department of Neurology, Wuxi People's Hospital, Wuxi Medical Center, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Nanjing Medical University, 299 Qingyang Road, Wuxi 214023, China
2 shared publications - Zheng Dai
Department of Neurology Wuxi People's Hospital Wuxi Medical Center The Affiliated Wuxi People's Hospital of Nanjing Medical University Nanjing Medical University Wuxi China
2 shared publications - Guanfeng Zeng
Department of Neurology, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, Institute of Neuroscience, The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, China
1 shared publication
Latest Publications
- 21 June 2025
- Published by Springer Nature in Molecular Neurobiology
- p. 1-11
Low-grade Inflammation Score: a Risk Factor for Stroke Recurrence in Patients With Intracranial Atherosclerotic Stenosis
Atherosclerosis is characterized by chronic low-grade inflammation (LGI) of the arteries. An elevated LGI score has been associated with the onset and recurrence of cardio-cerebrovascular diseases. The aim of this multicenter hospital-based prospective cohort study was to investigate the relationship between the LGI score and stroke recurrence in patients with intracranial atherosclerotic stenosis (ICAS).Consecutive acute ischemic stroke patients admitted within 1 week after onset were screened. The intracranial arteries were evaluated via computed tomographic angiography, magnetic resonance angiography or digital subtraction angiography. Patients with ICAS were enrolled and followed up for at least 1 year. The primary outcome was ischemic stroke recurrence. Cox regression and Kaplan‒Meier survival curves were used to analyze the association of the LGI score and stroke recurrence. A total of 932 patients were divided into 4 groups according to the LGI quartiles (Q1: < 3; Q2: 3–7; Q3: 7–10; Q4: > 10). At the end of follow-up (37.37 ± 15.24 months), 80 patients experienced at least one recurrent ischemic stroke. There were significant differences in total cholesterol levels, C-reactive protein levels, white blood cell counts, platelet counts, neutrophil-to-lymphocyte ratios, and stroke recurrence among the 4 groups. According to the multivariate adjusted models, compared to that for Q1, the hazard ratio for stroke recurrence in patients in Q4 was 2.748 (1.303–5.797). The Kaplan–Meier survival (ischemic stroke-free) curves according to quartiles of the LGI score also showed significant differences (log-rank test, P = 0.016). Our findings suggested that the LGI score was an independent risk factor for ischemic stroke recurrence in patients with ICAS.
- 21 June 2025
- Published by Springer Nature in Molecular Neurobiology
- p. 1-11
Low-grade Inflammation Score: a Risk Factor for Stroke Recurrence in Patients With Intracranial Atherosclerotic Stenosis
Atherosclerosis is characterized by chronic low-grade inflammation (LGI) of the arteries. An elevated LGI score has been associated with the onset and recurrence of cardio-cerebrovascular diseases. The aim of this multicenter hospital-based prospective cohort study was to investigate the relationship between the LGI score and stroke recurrence in patients with intracranial atherosclerotic stenosis (ICAS).Consecutive acute ischemic stroke patients admitted within 1 week after onset were screened. The intracranial arteries were evaluated via computed tomographic angiography, magnetic resonance angiography or digital subtraction angiography. Patients with ICAS were enrolled and followed up for at least 1 year. The primary outcome was ischemic stroke recurrence. Cox regression and Kaplan‒Meier survival curves were used to analyze the association of the LGI score and stroke recurrence. A total of 932 patients were divided into 4 groups according to the LGI quartiles (Q1: < 3; Q2: 3–7; Q3: 7–10; Q4: > 10). At the end of follow-up (37.37 ± 15.24 months), 80 patients experienced at least one recurrent ischemic stroke. There were significant differences in total cholesterol levels, C-reactive protein levels, white blood cell counts, platelet counts, neutrophil-to-lymphocyte ratios, and stroke recurrence among the 4 groups. According to the multivariate adjusted models, compared to that for Q1, the hazard ratio for stroke recurrence in patients in Q4 was 2.748 (1.303–5.797). The Kaplan–Meier survival (ischemic stroke-free) curves according to quartiles of the LGI score also showed significant differences (log-rank test, P = 0.016). Our findings suggested that the LGI score was an independent risk factor for ischemic stroke recurrence in patients with ICAS.
- Open Access
- 17 November 2022
- Published by Springer Nature in Cardiovascular Diabetology
- Vol. 21 (1) , 1-8
Association of triglyceride-glucose index with ischemic stroke recurrence in nondiabetic patients with small vessel occlusion: a multicenter hospital-based prospective cohort study
Background: Triglyceride-glucose (TyG) index is a simple and reliable surrogate marker of insulin resistance. Elevated TyG index was related to stroke recurrence. This study aimed to explore the associations between TyG index with ischemic stroke recurrence in nondiabetic patients with small vessel occlusion. Methods: From November 1, 2016 to February 28, 2021, consecutive acute ischemic stroke patients admitted within 1 week after onset were screened. The stroke mechanism was determined based on medical history, laboratory examinations, cardiac examinations, vascular examinations and neuroimaging. Nondiabetic patients with small vessel occlusion were enrolled and followed up for 1 year. The primary outcome was ischemic stroke recurrence. Logistic regression and Kaplan–Meier survival curve were used to analyze the association of the TyG index and stroke recurrence. Results: A total of 6100 acute ischemic stroke patients were screened, with 1970 nondiabetic patients with small vessel occlusion included and divided into 4 groups according to the TyG index quartiles (Q1: < 8.20; Q2: 8.20–8.53; Q3: 8.54–8.92; Q4: > 8.92). There were significant differences in age, body mass index, systolic blood pression, diastolic blood pressure, lipid-lowering agents, infarct location, fasting blood glucose, total cholesterol, triglyceride, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, uric acid, and stroke recurrence among the 4 groups. In the multi-adjusted models, compared to Q1 of the TyG index, the odds ratio for Q4 of the TyG index for stroke recurrence was 3.100 (1.366–8.019). The Kaplan–Meier survival (ischemic stroke-free) curves by quartiles of the TyG index also showed statistically significant differences (log-rank test, P = 0.004). Conclusions: Our findings suggested that the TyG index was associated with ischemic stroke recurrence in nondiabetic patients with small vessel occlusion, and it could be a valuable biomarker for assessing the risk of ischemic stroke recurrence in these patients.
- 17 November 2022
- Published by Springer Nature in Cardiovascular Diabetology
- Vol. 21 (1) , 1-8
Open AccessAssociation of triglyceride-glucose index with ischemic stroke recurrence in nondiabetic patients with small vessel occlusion: a multicenter hospital-based prospective cohort study
Background: Triglyceride-glucose (TyG) index is a simple and reliable surrogate marker of insulin resistance. Elevated TyG index was related to stroke recurrence. This study aimed to explore the associations between TyG index with ischemic stroke recurrence in nondiabetic patients with small vessel occlusion. Methods: From November 1, 2016 to February 28, 2021, consecutive acute ischemic stroke patients admitted within 1 week after onset were screened. The stroke mechanism was determined based on medical history, laboratory examinations, cardiac examinations, vascular examinations and neuroimaging. Nondiabetic patients with small vessel occlusion were enrolled and followed up for 1 year. The primary outcome was ischemic stroke recurrence. Logistic regression and Kaplan–Meier survival curve were used to analyze the association of the TyG index and stroke recurrence. Results: A total of 6100 acute ischemic stroke patients were screened, with 1970 nondiabetic patients with small vessel occlusion included and divided into 4 groups according to the TyG index quartiles (Q1: < 8.20; Q2: 8.20–8.53; Q3: 8.54–8.92; Q4: > 8.92). There were significant differences in age, body mass index, systolic blood pression, diastolic blood pressure, lipid-lowering agents, infarct location, fasting blood glucose, total cholesterol, triglyceride, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, uric acid, and stroke recurrence among the 4 groups. In the multi-adjusted models, compared to Q1 of the TyG index, the odds ratio for Q4 of the TyG index for stroke recurrence was 3.100 (1.366–8.019). The Kaplan–Meier survival (ischemic stroke-free) curves by quartiles of the TyG index also showed statistically significant differences (log-rank test, P = 0.004). Conclusions: Our findings suggested that the TyG index was associated with ischemic stroke recurrence in nondiabetic patients with small vessel occlusion, and it could be a valuable biomarker for assessing the risk of ischemic stroke recurrence in these patients.